MedTrace Logo

Role of Salbutamol and Furosemide in TTN

NCT03208894 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-07-06

No results posted yet for this study

Summary

to see the effects of slabutamol and IV furosemide in the treatment of transient tachypnea of newborn

Conditions

  • Transient Tachypnea of the Newborn

Interventions

DRUG

Furosemide Injection

efficacy of salbutamol and furosemide in TTN

Sponsors & Collaborators

  • Armed Forces Hospital, Pakistan

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Hour
Max Age
7 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-01
Primary Completion
2017-05-30
Completion
2017-06-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03208894 on ClinicalTrials.gov